SCHEMBL25009358

SCHEMBL25009358

CCSc1oc(-c2ccccc2)nc1S(=O)(=O)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 1.00
TSHR P16473 5/20 1.00
NPSR1 Q6W5P4 4/20 1.00
HSD17B10 Q99714 4/20 1.00
MAPK1 P28482 2/20 1.00
MAPT P10636 10/20 0.70
HPGD P15428 4/20 0.70
HTT P42858 2/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
TP53 P04637 4/20 0.68
KDM4E B2RXH2 2/20 0.63
KMT2A Q03164 2/20 0.63
MEN1 O00255 1/20 0.63
LMNA P02545 1/20 0.62
POLB P06746 5/20 0.60
RXFP1 Q9HBX9 1/20 0.60
GAA P10253 1/20 0.59
ALOX15 P16050 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25009162 0.91 ALDH1A1 (0.84) ALDH1A1TSHRNPSR1HSD17B10MAPK1
SCHEMBL25009165 0.91 ALDH1A1 (0.84) ALDH1A1TSHRNPSR1HSD17B10MAPK1
SCHEMBL25009360 0.91 ALDH1A1 (0.84) ALDH1A1TSHRNPSR1HSD17B10MAPK1
SCHEMBL25011047 0.84 KDM4E (0.74) ALDH1A1TSHRNPSR1HSD17B10MAPK1
SCHEMBL3028204 0.82 MAPT (0.77) ALDH1A1TSHRNPSR1HSD17B10MAPK1
SCHEMBL25009356 0.82 TSHR (0.73) ALDH1A1TSHRNPSR1HSD17B10MAPK1
SCHEMBL25010450 0.82 TSHR (0.73) ALDH1A1TSHRNPSR1HSD17B10MAPK1
SCHEMBL25010123 0.82 MAPT (0.72) ALDH1A1TSHRNPSR1HSD17B10MAPK1
SCHEMBL25009620 0.80 TSHR (0.75) ALDH1A1TSHRNPSR1HSD17B10MAPK1
SCHEMBL25009351 0.80 ALDH1A1 (0.67) ALDH1A1TSHRNPSR1HSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230041576-A1 METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY NFKBIA, IKBKB, NFKB2 ALDH1A1 4286/4885TSHR 4634/4885NPSR1 4365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.